Cipla
Search results
Our global manufacturing footprint helps us deliver quality pharmaceuticals around the world.
Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals Inc. (LPI), the company's US subsidiary is a $891 million enterprise. It has a presence in the branded and generics markets of the US. In the branded business, Lupin operates in the CVS and Pediatric segments.
Lupin’s commitment to innovation and patient-centricity has fueled its success in therapeutic areas such as cardiovascular health, tuberculosis, diabetes, respiratory, gastrointestinal disorders, and women’s health.
23 hours ago · Shares of Lupin soared 7.9 per cent to hit an eight-year high of Rs 1,749 on the BSE on Thursday, backed by heavy volumes on expectations of a robust earnings outlook. The stock has nearly doubled in value over the last year and trades at consensus valuations of 33 times its FY25 earnings estimates ...
3 days ago · Lupin, a pharmaceutical company, has launched a new subsidiary named Lupin Manufacturing Solutions (LMS) to enter the Contract Development and Manufacturing Organization (CDMO) business. Abdelaziz Toumi (Abdel), with extensive experience in biotech, pharma, and CDMO sectors across multiple continents, has been appointed as the CEO of LMS.
Jun 28, 2024 · Lupin Ltd., incorporated in the year 1983, is a Large Cap company (having a market cap of Rs 74,303.00 Crore) operating in Pharmaceuticals sector. Lupin Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Services, Export Incentives and Other Operating Revenue for the year ending 31-Mar-2023.
1 day ago · Lupin shares rose over 6 per cent on BSE on Thursday after brokerage Kotak Securities double upgraded the pharma firm to ‘add’. KIE’s bullishness over Lupin stems from the drugmaker’s strong US portfolio which makes it well-poised to surprise positively on Street’s estimates in the US in FY25 and FY26. Factoring that in, the brokerage ...
